Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06217783
- Status
- Recruiting
Conditions
- Oncologic Complications and Emergencies
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Introcan Safety IV Catheter — DEVICEGiven by IV
Study Details
To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.
Key Dates
- Start date
- Mar 27, 2024
- Status verified
- Dec 2025
- Primary completion
- Dec 1, 2027
- Completion
- Dec 1, 2027
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Group AParticipants will receive a catheter that is up to 1.75 inches long based on what the nurse thinks is best for you.
- Experimental: Group BParticipants will receive a catheter that is either 1.75 or 2.5 inches long based on what the nurse thinks is best for you.
Primary Outcome Measure
Safety and adverse events (AEs) [ Time Frame: Through study completion; an average of 1 year. ]
Central Contacts
- Jonathan Rowland, MD(832) 450-8954
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | Jonathan Rowland, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site